Logo image
GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease
Journal article   Open access   Peer reviewed

GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease

Carlos H Martinez, Christine M Freeman, Joshua D Nelson, Susan Murray, Xin Wang, Matthew J Budoff, Mark T Dransfield, John E Hokanson, Ella A Kazerooni, Gregory L Kinney, …
Respiratory research, Vol.18(1), pp.42-42
02/28/2017
DOI: 10.1186/s12931-017-0521-1
PMCID: PMC5331711
PMID: 28245821
url
https://doi.org/10.1186/s12931-017-0521-1View
Published (Version of record) Open Access

Abstract

Growth differentiation factor-15 (GDF-15), a cytokine associated with cardiovascular mortality, increases during chronic obstructive pulmonary disease (COPD) exacerbations, but any role in stable COPD is unknown. We tested associations between GDF-15 and subclinical coronary atherosclerosis, assessed by coronary artery calcium (CAC) score, in COPD subjects free of clinical cardiovascular disease (CVD). Cross-sectional analysis of COPD participants (GOLD stages 2-4) in the COPDGene cohort without CVD at enrollment, using baseline CAC (from non-EKG-gated chest computed tomography) and plasma GDF-15 (by custom ELISA). We used multinomial logistic modeling of GDF-15 associations with CAC, adjusting for demographics, baseline risk (calculated using the HEART: Personal Heart Early Assessment Risk Tool (Budoff et al. 114:1761-1791, 2006) score), smoking history, measures of airflow obstruction, emphysema and airway disease severity. Among 694 participants with COPD (47% women, mean age 63.6 years) mean GDF-15 was 1,304 pg/mL, and mean CAC score was 198. Relative to the lower GDF-15 tertile, higher tertiles showed bivariate association with increasing CAC score (mid tertile odds ratio [OR] 1.80, 95% confidence interval [CI] 1.29, 2.51; higher tertile OR 2.86, CI 2.04, 4.02). This association was maintained after additionally adjusting for baseline CVD risk, for co-morbidities and descriptors of COPD severity and impact, markers of cardiac stress (N-terminal pro-B-type natriuretic peptide, troponin T) and of inflammation (Interleukin-6), and in subgroup analysis excluding men, diabetics, current smokers or those with limited ambulation. In ever-smokers with COPD free of clinical CVD, GDF-15 contributes independently to subclinical coronary atherosclerosis. ClinicalTrials.gov, NCT00608764 . Registered 28 January 2008.
Comorbidity Pulmonary Disease, Chronic Obstructive - diagnosis Reproducibility of Results Humans Middle Aged Risk Factors Male Asymptomatic Diseases Biomarkers - blood Coronary Artery Disease - blood Pulmonary Disease, Chronic Obstructive - epidemiology Incidence Growth Differentiation Factor 15 - blood Coronary Artery Disease - diagnosis Sensitivity and Specificity Pulmonary Disease, Chronic Obstructive - blood Female Aged Coronary Artery Disease - epidemiology Causality Michigan - epidemiology

Details

Metrics

Logo image